The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3,4-dichlorophenyl)-6-(methyloxy)-7-{[(5-piperidin-3-yl-1,2,4-oxadiazol-3-yl)methyl]oxy}quinazolin-4-amine ID: ALA3985163
PubChem CID: 53630953
Max Phase: Preclinical
Molecular Formula: C23H22Cl2N6O3
Molecular Weight: 501.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCNC2)n1
Standard InChI: InChI=1S/C23H22Cl2N6O3/c1-32-19-8-15-18(27-12-28-22(15)29-14-4-5-16(24)17(25)7-14)9-20(19)33-11-21-30-23(34-31-21)13-3-2-6-26-10-13/h4-5,7-9,12-13,26H,2-3,6,10-11H2,1H3,(H,27,28,29)
Standard InChI Key: SHKAUSIXYOWPKS-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
34.5611 -3.5769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2708 -3.1674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2680 -2.3448 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5593 -1.9395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8531 -3.1679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8554 -2.3501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1494 -1.9411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4407 -2.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4424 -3.1695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1489 -3.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7330 -1.9402 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7328 -1.1230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7357 -3.5798 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5559 -1.1223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2618 -0.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9707 -1.1177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6762 -0.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6731 0.1116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9587 0.5234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2562 0.1112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3785 0.5245 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.3855 -1.1127 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.7376 -4.3970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0309 -4.8072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2805 -4.4791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7351 -5.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1454 -5.7944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9443 -5.6225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9216 -5.0068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5888 -4.2594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7797 -4.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2973 -4.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6300 -5.5818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4452 -5.6691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
8 11 1 0
11 12 1 0
9 13 1 0
4 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
17 22 1 0
13 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 24 2 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.37Molecular Weight (Monoisotopic): 500.1130AlogP: 5.12#Rotatable Bonds: 7Polar Surface Area: 107.22Molecular Species: BASEHBA: 9HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.30CX LogP: 4.40CX LogD: 2.51Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -1.46
References 1. (2009) Receptor-type kinase modulators and methods of use,